Snehalatha, Chamukuttan

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)

Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 1,881

Diabetes in Asia

Ramachandran, A., Wan Ma, R. C., & Snehalatha, C. (2010) · The Lancet

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 782

Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial

Ramachandran, A., Snehalatha, C., Ram, J., Selvam, S., Simon, M., Nanditha, A., Shetty, A. S., Godsland, I. F., Chaturvedi, N., Majeed, A., et al. (2013) · The Lancet Diabetes & Endocrinology

Mobile Health and mHealth ApplicationsMobile Learning in Education

Cited by 330

Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease

Hitman, G. A., Hawrami, K., McCarthy, M. I., Viswanathan, M., Snehalatha, C., Ramachandran, A., Tuomilehto, J., Tuomilehto-Wolf, E., Nissinen, A., & Pedersen, O. (1995) · Diabetologia

Genetic Associations and EpidemiologyDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 124

Comparison of two Actigraph models for assessing free-living physical activity in Indian adolescents

Corder, K., Brage, S., Ramachandran, A., Snehalatha, C., Wareham, N., & Ekelund, U. (2007) · Journal of Sports Sciences

Physical Activity and HealthContext-Aware Activity Recognition Systems

Cited by 120

Low risk threshold for acquired diabetogenic factors in Asian Indians

Ramachandran, A., Snehalatha, C., & Vijay, V. (2004) · Diabetes Research and Clinical Practice

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 109

Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2)

Ramachandran, A., Snehalatha, C., Mary, S., Selvam, S., Kumar, C. K. S., Seeli, A. C., & Shetty, A. S. (2009) · Diabetologia

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 105

Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1)

Snehalatha, C., Mary, S., Selvam, S., Sathish Kumar, C. K., Shetty, S. B. A., Nanditha, A., & Ramachandran, A. (2009) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 64

mDiabetes initiative using text messages to improve lifestyle and health-seeking behaviour in India

Ramachandran, A., Kumar, R., Nanditha, A., Raghavan, A., Snehalatha, C., Krishnamoorthy, S., Joshi, P., & Tesfaye, F. (2018) · BMJ Innovations

Mobile Health and mHealth ApplicationsSocial Media in Health Education

Cited by 22